Therefore, targeting the PGE2-EP4 signaling pathway may represent a novel strategy for the treatment of mastitis, helping to alleviate inflammatory damage while potentially replacing the use of antibiotics and reducing the risk of resistance. The gene discussed is PTGER4; the disease is mastitis.